Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.

MLA

Yang, Wanqi, et al. “Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.” Vaccines, vol. 12, no. 8, Aug. 2024. EBSCOhost, https://doi.org/10.3390/vaccines12080892.

APA

Yang, W., González, P. A., Xin, Q., Reyes, M. R. D. L., Villalobos, R. E., Borja-Tabora, C. F. C., Bermal, N. N., Kalergis, A. M., Yu, D., Wu, W., Bueno, S. M., Huo, L., Calvo, M., Qinf Study Group, Zeng, G., & Li, J. (2024). Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial. Vaccines, 12(8). https://doi.org/10.3390/vaccines12080892

Chicago

Yang, Wanqi, Pablo A González, Qianqian Xin, Mari Rose De Los Reyes, Ralph Elvi Villalobos, Charissa Fay Corazon Borja-Tabora, Nancy Nazaire Bermal, et al. 2024. “Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.” Vaccines 12 (8). doi:10.3390/vaccines12080892.